Our Company was originally incorporated as `Continental Papers Limited' under the Companies Act, 1956, as a public limited company, pursuant to the certificate of incorporation dated February 26, 1982 issued by the Registrar of Companies, Delhi & Haryana. Gouthamchand Sohanlal Chowdhary, Sambhav Gautam Chowdhary and Shreyans Gautam Chowdhary the Promoters of our Company acquired the entire shareholding, assets and liabilities of Continental Papers Limited pursuant to Agreement to sell and transfer dated February 22, 2012 between Continental Construction Limited and Gouthamchand Sohanlal Chowdhary and associates. Thereafter, the name of our Company was changed to `Sanstar Limited', pursuant to resolution passed by the board of directors on March 9, 2012 and approved by the shareholders in their EGM held on March 16, 2012. A fresh certificate of incorporation dated April 2, 2012, consequent upon change of name was issued to our Company by the Registrar of Companies, Delhi & Haryana.Subsequently, pursuant to a Scheme of Amalgamation entered into between our Company and Sanstar Biopolymers Limited (`Transferor Company') under Section 232 of the Companies Act, 2013 and approved by the NCLT, Ahmedabad vide order dated November 23, 2023, the Transferor Company' Undertaking was merged into our Company as a going concern.Major Events and Milestones:2006-Erstwhile Sanstar Biopolymers Limited commenced operations at the Kutch Facility.2008-Erstwhile Sanstar Biopolymers Limited commenced its export operations.2012-The entire shareholding, assets and liabilities of Continental Papers Limited was acquired by the present Promoters pursuant to Agreement to sell and transfer dated February 22, 2012. Subsequently the name was changed from Continental Papers Limited to Sanstar Limited pursuant to the Fresh Certificate of Incorporation dated April 2, 2012 issued by Registrar of Companies, Delhi and Haryana.-Established research and development centre.2015-Sanstar Limited commenced setting up the Dhule Facility.2017-Commencement of operations at the Dhule Facility2018-Sanstar Limited commenced its export operations.2023-Sanstar Limited earned revenue achieved more than ? 11,000 million-Export operations of erstwhile Sanstar Biopolymers Limited extended to 49 countries in South East Asia, Latin America, Australia as well as some products to USA and Canada.-Sanstar Limited initiated new line of additional 1,000 tons per day of installed capacity at Dhule Facility with plant for maize starch, liquid glucose, dextrose monohydrate and dextrose anhydrous estimated to commence commercial manufacturing during Fiscal 2026. (Source Company commissioned TEV Report from Dun & Bradstreet)-Merger of erstwhile Sanstar Biopolymers Limited with our Company pursuant to Scheme of Amalgamation. Consequently all the assets and liabilities of erstwhile Sanstar Biopolymers Limited were transferred to Sanstar Limited.-Acquisition of ECL